Dramatically reduces diagnostic cost and sample use
Allows for much quicker health treatment to patients
Dramatically reduces diagnostic cost and sample use
Allows for much quicker health treatment to patients
Creates a central data bank for improved medical management
Empowers decentralized clinical diagnostics and faster patient triage anywhere
Minimizes human error during a test with programmed process
Array-based detection scheme with a versatility of analytes
ALiA® Point-Of-Care Testing (POCT) platform is an end-to-end solution that delivers multiple results with a minimal drop of sample in 15 minutes in a Point-Of-Care (POC) setting.
ALiA® is a portable and highly integrated microfluidic BioChip platform for time critical and life threatening disease diagnostics and fast-track triage at the medical front-line, with a whole series of BioChip applications for infectious diseases diagnostics and healthcare management.
ALiA® is a miniaturized solution that consists of a microfluidic-microarray BioChip, an optical unit, an integrated control unit and a power supply system, which can run the BioChip without any fluidic interfaces to the instrument.
The platform includes a set of fluorescent immunoassay (FIA) analyzer and multifavious one-time use BioChip. The BioChip is based on a user-friendly, self-contained microfluidic Lab-On-Chip (LOC) with a protein-based microarray. The FIA analyzer is a fully automated device built with an intelligent optical sensing system. It is designed for medical professionals and less equipped workers at front lines to make faster clinical decisions and patient triage.
Address: Unit 2, 5/F, Wah Lai Industrial Centre, 10 – 14 Kwei Tei Street, Fo Tan, Hong Kong
Tel: + 852 2698 9903
Fax: +852 3619 5770